Swing Therapeutics
San Francisco, CA · United States
Specialization: Prescription digital therapy for fibromyalgia
Key Differentiator
Stanza received FDA De Novo authorization in 2023 for fibromyalgia symptoms in adults.
Core Services
Stanza prescription digital behavioural therapy; Virtual care services; Clinical partner programs
Capabilities
Market Intelligence
Founded in 2019. Phase 3 data for Stanza were published in The Lancet in 2024, and Highmark covers the therapy.
Website
swingtherapeutics.comSimilar Companies
Think Research
Toronto, ON · Clinical Decision Support
TSX: THNK; Canadian digital health company serving 400+ hospitals/healthcare organizations; clinical decision support for drug safety and prescribing
Winterlight Labs
Toronto, ON · Speech-based digital biomarkers for clinical trials
Analyzes short speech samples to measure cognitive and mood changes in clinical trials.
Click Therapeutics
New York, NY · Prescription digital therapeutics
Co-develops FDA-cleared software treatments with pharma partners, such as Rejoyn with Otsuka.
Koneksa Health
New York, NY · Digital biomarkers and remote monitoring for trials
Builds digital biomarkers from remote data, such as its Parkinson's study that Merck and Regeneron joined through a data syndication program.
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.